Search
Now showing items 1-1 of 1
Tocilizumab Treatment In Juvenile Idiopathic Arthritis Patients: A Single Center Experience
(2019)
Tocilizumab is a monoclonal antibody against interleukin-6 that has recently emerged as an alternative treatment modality for juvenile idiopathic arthritis (JIA). In the present study, we aimed to discuss the clinical and ...